This training program is designed to prepare physicians or medical scientists for research careers in endocrinology and metabolism. Training is aimed at promoting: 1) understanding, design and use of biochemical, physiological and molecular biological approaches to endocrine and metabolic problems; and 2) proficiency in laboratory and clinical investigation techniques. Individuals who complete the program will be capable of independent investigation and translating research accomplishments into important advances with clinical relevance. Training will emphasize research in bone and mineral metabolism, hormone receptor biology, diabetes mellitus, mechanisms of hormone action and cell and molecular biology. The research experience will be supervised by preceptors who have demonstrated excellence in research. Trainees will be, in general, board-eligible or certified physicians who have training in internal medicine, pediatrics or obstetrics-gynecology and wish to pursue careers in endocrine/metabolic research. They may also be non-physician graduates of science programs who wish to specialize in endocrine related research. Selected on the basis of college and medical school performances and experience as medical house officers or post- doctoral trainees, trainees will be individuals with a high probability of developing into successful independent investigators. Appointments will last 2 to 3 years, the minimal time essential for obtaining the goals of the program. Physician trainees will have 2 to 4 years of postdoctoral experience when they enter the program, while medical scientists will train immediately after doctoral degree is awarded, or following 1 to 3 years of postdoctoral training. Training facilities are a part of Duke University Medical Center and include: 1) outpatient/inpatient facilities; 2) a Clinical Research Center; 3) a Nutrition Center; and 4) fully equipped basic research laboratories.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007012-24
Application #
2905027
Study Section
Special Emphasis Panel (SRC)
Program Officer
Margolis, Ronald N
Project Start
1975-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
24
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Rhea, Elizabeth M; Salameh, Therese S; Gray, Sarah et al. (2018) Ghrelin transport across the blood-brain barrier can occur independently of the growth hormone secretagogue receptor. Mol Metab 18:88-96
Page, Laura C; Gastaldelli, Amalia; Gray, Sarah M et al. (2018) Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans. Diabetes 67:1976-1985
Douros, Jonathan D; Lewis, Alfor G; Smith, Eric P et al. (2018) Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a ?-Cell Glucagon-Like Peptide 1 Receptor. Diabetes 67:1504-1511
Wagner, Gregory R; Bhatt, Dhaval P; O'Connell, Thomas M et al. (2017) A Class of Reactive Acyl-CoA Species Reveals the Non-enzymatic Origins of Protein Acylation. Cell Metab 25:823-837.e8
Anderson, Kristin A; Huynh, Frank K; Fisher-Wellman, Kelsey et al. (2017) SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion. Cell Metab 25:838-855.e15
Wagner, Gregory R; Hirschey, Matthew D (2017) A Prob(e)able Route to Lysine Acylation. Cell Chem Biol 24:126-128
Ruel, Ewa; Thomas, Samantha; Dinan, Michaela A et al. (2016) Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. Endocrine 52:579-86
McVay, Megan A; Voils, Corrine I; Geiselman, Paula J et al. (2016) Food preferences and weight change during low-fat and low-carbohydrate diets. Appetite 103:336-343
Ruel, Ewa; Thomas, Samantha; Dinan, Michaela et al. (2015) Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab 100:1529-36
Okorodudu, Daniel E; Bosworth, Hayden B; Corsino, Leonor (2015) Innovative interventions to promote behavioral change in overweight or obese individuals: A review of the literature. Ann Med 47:179-85

Showing the most recent 10 out of 57 publications